GPT and metabolic dysfunction-associated steatotic liver disease: Earlier studies investigated the cumulative dose of MTX-associated nonalcoholic fatty liver disease (NAFLD) with transaminitis, and it was found to have a significant positive correlation with the ALT level [23].